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Abstract
Respiratory syncytial viral (RSV) infections are a frequent cause of chronic obstructive pulmonary disease (COPD)
exacerbations, which are a major factor in disease progression and mortality. RSV is able to evade antiviral defenses to
persist in the lungs of COPD patients. Though RSV infection has been identified in COPD, its contribution to cigarette
smoke-induced airway inflammation and lung tissue destruction has not been established. Here we examine the long-term
effects of cigarette smoke exposure, in combination with monthly RSV infections, on pulmonary inflammation, protease
production and remodeling in mice. RSV exposures enhanced the influx of macrophages, neutrophils and lymphocytes to
the airways of cigarette smoke exposed C57BL/6J mice. This infiltration of cells was most pronounced around the
vasculature and bronchial airways. By itself, RSV caused significant airspace enlargement and fibrosis in mice and these
effects were accentuated with concomitant smoke exposure. Combined stimulation with both smoke and RSV
synergistically induced cytokine (IL-1a, IL-17, IFN-c, KC, IL-13, CXCL9, RANTES, MIF and GM-CSF) and protease (MMP-2, -8,
-12, -13, -16 and cathepsins E, S, W and Z) expression. In addition, RSV exposure caused marked apoptosis within the airways
of infected mice, which was augmented by cigarette smoke exposure. RSV and smoke exposure also reduced protein
phosphatase 2A (PP2A) and protein tyrosine phosphates (PTP1B) expression and activity. This is significant as these
phosphatases counter smoke-induced inflammation and protease expression. Together, these findings show for the first
time that recurrent RSV infection markedly enhances inflammation, apoptosis and tissue destruction in smoke-exposed
mice. Indeed, these results indicate that preventing RSV transmission and infection has the potential to significantly impact
on COPD severity and progression.
Citation: Foronjy RF, Dabo AJ, Taggart CC, Weldon S, Geraghty P (2014) Respiratory Syncytial Virus Infections Enhance Cigarette Smoke Induced COPD in
Mice. PLoS ONE 9(2): e90567. doi:10.1371/journal.pone.0090567
Editor: Navneet K. Dhillon, University of Kansas Medical Center, United States of America
Received November 6, 2013; Accepted February 3, 2014; Published February 28, 2014
Copyright:  2014 Foronjy et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants made available to P.G. (Flight Attendant Medical Research Institute (YCSA 113380)) (http://www.famri.org/intro/)
and to R.F. (US National Institutes of Health 5R01HL098528-04) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pgeraghty@chpnet.org
Introduction
Chronic obstructive pulmonary disease (COPD) is the third
leading cause of death in the US [1] and a foremost cause of
morbidity. Indeed, those with the disease have difficulty perform-
ing simple daily tasks such as walking, bathing and feeding
themselves. The economic costs of COPD are substantial both in
terms of healthcare expenditures and lost productivity [2,3]. Acute
exacerbations of COPD, defined as a sudden worsening of COPD
symptoms (shortness of breath, quantity and color of phlegm) that
typically lasts for several days, are a major contributor to disease
morbidity and mortality [4,5]. Indeed, those with 3 or more
exacerbations over a five-year time period had a survival rate of
30% compared to a survival rate of 80% for those without an
exacerbation [6]. In the Perception of Exacerbations of Chronic
Obstructive Pulmonary Disease (PERCEIVE) survey, 89% of
COPD subjects experienced at least one exacerbation in the past
year and 21% of these exacerbations resulted in hospital admission
[7]. These findings show that exacerbations are common in
COPD and impact significantly on the natural history of the
disease. Thus, these studies underscore the importance of
determining the etiologic factors underlying COPD exacerbations.
Infectious agents, such as viral infections, have been implicated
in the pathogenesis of COPD exacerbations [8,9]. Rhinovirus,
influenza and respiratory syncytial virus (RSV) are frequently
detected in the respiratory tract of COPD patients [10]. It is
estimated that almost everyone has experienced at least one RSV
infection as an infant [11] but immunity against RSV infections is
uncommon. RSV infections are frequently reported in infants, the
elderly and immunocompromised patients but also in healthy
adults [12,13]. RSV is detected in stable COPD patients [14] but
whether RSV plays a role in COPD progression is undetermined.
RSV readily infects the airway epithelium [11], which could
significantly contribute to inflammation and airway disease
progression. In fact, infection with RSV is associated with airway
inflammation and an accelerated decline in FEV1 in COPD
patients [15]. Moreover, the presence of RSV infection worsens
outcomes in COPD patients hospitalized for disease exacerbations
[16]. Once infected, RSV can persist in the lungs of COPD
patients by antagonizing antiviral cytokines, mimicking chemo-
kines, escaping detection through antigenic drift and by entering
immune-privileged cells such as pulmonary neurons [17]. Though
cigarette smoke impairs antiviral responses that clear RSV [18,19],
the consequence of persistent RSV infection on key disease
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parameters and outcomes in COPD has yet to be determined and
larger clinical studies are need to identify if smoke exposure is a
risk factor for increased RSV infections in COPD patients [20].
Few studies have examined the effects of cigarette smoking and
viral infections in vivo and the subsequent impact on lung
morphology [21,22]. Environmental tobacco smoke has been
associated with increased RSV infection and hospitalization in
children [23], however little is known about the clinical
implications in COPD, a disease that RSV frequently colonizes
[15,24]. Therefore this study aimed to examine how combined
RSV infections and smoke exposure would impact on airway
inflammation, protease production, apoptosis, lung tissue destruc-
tion and phosphatase activity. We hypothesized that dual
stimulation could lead to excessive inflammation and an enhanced
disease state closer to human COPD. We show that RSV infection
enhances cigarette smoke induced immune cell infiltration,
cytokine and protease production and airway remodeling.
Collectively, these data demonstrate that viral infection alone or
in combination with smoke exposure can significantly contribute
to airway remodeling and disease progression.
Methods
Ethics Statement
All animal procedures performed in this study are in accordance
with Institutional Animal Care and Use Committee (IACUC)
guidelines, and have been approved by St. Luke’s Roosevelt’s
Hospital IACUC at Mount Sinai School of Medicine.
RSV Culture
Human RSV strain A2 (ATCC, Manassas, VA; #VR-1540)
was infected at a multiplicity of 0.1 into Hep2 cells. The virus was
allowed to grow for 5 days at 37uC in a 5% CO2 atmosphere. The
infected Hep2 monolayers were collected and the virus was
released by sonication. Cell debris was removed by centrifugation
at 2500 g for 5 minutes at 4uC. Virus was collected by centrifuging
the supernatant for 2 hours at 220006g at 4uC. Virus were
suspended in culture media and snap frozen and maintained at 2
80uC. Infectious virus titers were determined on Hep2 cells by
performing serial dilutions of the RSV stocks and counting
infected cells stained for indirect immunofluorescence with an
RSV F-specific monoclonal antibody (Abcam, Cambridge, MA).
Additionally, plaque assays were performed as previously de-
scribed [25] on Hep2 cells using methyl cellulose overlay media
(R&D Systems) and staining with 0.5 mg/ml thiazolyl blue
tetrazolium bromide (MTT; Sigma Aldrich) solution in PBS for
3 hours at 37uC. Non-infected Hep2 cell cultures were processed
in the same manner as RSV infected cells and the resulting sample
collection was used as a mock control.
Cigarette Smoke Exposure and RSV Infection
C57BL/6J mice were purchased from the Jackson Laboratory
(Bar Harbor, ME). All mice were maintained in a specific
pathogen-free facility at St. Luke’s Roosevelt’s Hospital. 12-week-
old mice were used at the initiation point for all experiments and
each experimental parameter had 12 animals per group. Mice
were anesthetized by intraperitoneal injection of a mixture of
ketamine and xylazine. Mice were exposed to cigarette smoke in a
chamber (Teague Enterprises, Davis, CA) for four hours a day, 5
days per week at a total particulate matter concentration of
80 mg/m3. Smoke exposure was continued for 6 months with
RSV dosing or mock administered 2 weeks after initiation of
smoke exposures and continued monthly. RSV was intranasally
administered at a dose of 16106 pfu. RSV infected animals were
housed separately from non-infected animals. Animals were
monitored for discomfort, weight loss and any notable unusual
behavior. Body weight and survival were measured every 5 days,
for 6 months. Animals were sacrificed 12 hours after the last smoke
exposure, which was 10 days after the last RSV or mock
administration. The lungs underwent pressure-fixation and
morphometric analysis in accordance with our previously
published protocol [26] and in accordance with the ATS/ERS
issue statement on quantitative assessment of lung structure [27].
Bronchoalveolar lavage fluid (BALF) isolation was performed on
the mice. All mouse experiments were carried in strict accordance
with institutional protocols.
Lung Titers and RSV N Copy Number
Lungs of infected mice were excised 10 days post the last RSV
infection and homogenized using a mechanical homogenizer
(Kinematica, Bohemia, NY, USA). The viral titers in the
homogenates were quantified by plaque assay on Hep2 cells.
The concentration of RSV N (pg) was determined by PCR based
on a standard curve. The following primers were used at 100 pmol
each: 59-TGG GAG AGG TAG CTC CAG AA-39 and 59-AGA
ATC TGT CCC CTG CTG CTA-39. Ct was plotted against
known RSV standards. A Ct-value of 45 was chosen as the cut-off
value for sample infection positive. Results are represented as
natural log pico grams (pg).
Histological Analysis
Fixed tissue was H&E stained for inflammation and fibrosis
scoring and mean linear intercept (MLI) determination. Matrix
accumulation was assessed on fixed tissue with trichrome
evaluations using a commercial available kit (Abcam; ab150686).
Histological analysis of H&E stained slides were used to determine
perivascular vascular inflammation (PVI) and bronchial inflam-
mation using a modified quantification schema [28,29]. Briefly,
the intensity of perivascular or bronchial inflammation was scored
on a scale of 1 to 9. 0, was no inflammation; 1–3, was scant cells
but not forming a defined layer; 4–6, one to three layers of cells
surrounding the vessel; 7–9, four or greater layers of cells
surrounding the vessel or bronchial. Every vascular vessel and
bronchus was measured on multiple lung lobes from 3 different
depths of sectioned tissue. The validated semiquantitative Ashcroft
score was used to score pulmonary fibrosis; scoring from 0 (normal
lung) to 8 (total fibrous obliteration of the field) under 100X
magnification using trichrome stained sections [30,31]. Each
histology analysis was performed on 12 animals per treatment
group.
Protease and Cytokine Measurements
MMP, cathepsin and cytokine gene expression was performed
by qPCR using validated Taqman probes (Life technologies/
Applied Biosystems, Carlsbad, CA). RNA was isolated using
Qiagen RNeasy kit following tissue homogenizing and cDNA was
reverse transcribed using the Applied Biosystems high capacity
cDNA kit. qPCR was performed on the Bio-Rad CFX384 real
time system. No cDNA template, no reverse transcriptase treated
samples and no DNA polymerase controls were examined for each
qPCR throughout this study. Exogenous (human targets) and
endogenous (Actin) positive controls were also monitored for each
assay. All qPCR results are represented as relative quantification
(RQ) compared to the mock and room air treated animals and
corrected to actin levels. Several MMP and cytokine levels were
measured in BALF using a beads assay (EMD Millipore, Billerica,
MA) with the BioRad Bio-Plex 200 system (BioRad, Hercules,
CA). Cathepsin S activity assays were performed on BALF as
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previously described [32]. BALF collagenase activity was deter-
mined by a colorimetric ninhydrin method, as previously
described [33]. Results of enzyme activity are expressed as a
relative percentage of activity compared of the mock and room air
treated animal group. BALF gelatinase activity was determined by
gelatin zymography as described previously [34].
Figure 1. Chronic cigarette smoke exposure enhances RSV pathology in mouse airways. (A) Protocol for administering A2 RSV strain and
cigarette smoke to C57BL/6J mice. C57BL/6J mice (n = 12 animals/group) were infected with monthly RSV infections in combination with 6 months of
smoke exposure. (B) Changes in body weight of each treatment group of C57BL/6J mice, represented as a percentage of initial weight of mock and
room air treated mice at the beginning of this study. p values shown, comparing both groups by 2-way ANOVA. (C) RSV N copy number was
determined 10 days post final infection in the lungs of C57BL/6J mice infected with 16106 pfu of RSV A2 strain and exposed to either room air or
cigarette smoke for 6 months. Absolute RSV N concentration was represented as natural log pg. (D) BALF immune cellularity was measured and
changes were observed following repeat monthly RSV infections in combination with 6 months of smoke exposure on total immune cell number,
macrophages, neutrophils and lymphocytes. Graphs are represented as mean 6 S.E.M., where each measurement was performed 3 times on 12
animals/group. p values shown, comparing both treatments connected by a line.
doi:10.1371/journal.pone.0090567.g001
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Intracellular Signaling
Lung tissue protein from mice was homogenized in RIPA
buffer, centrifuged at 13,0006g for 10 minutes and supernatants
collected. Immunoblots were conducted to determine levels of
cathepsin E, S, G, K, W, Z (all cathepsin antibodies from Santa
Cruz Biotechnology, Paso Robles, CA), MMP-28 (EMD Milli-
pore) and actin (Cell Signaling Technologies, Danvers, MA).
Chemiluminescence detection was performed using the Bio-Rad
Laboratories Molecular Imager ChemiDoc XRS+ imaging
Figure 2. RSV infections enhance cigarette smoke induced airway enlargements and fibrosis. (A) Perivascular and (B) bronchial
inflammation was recorded in mice exposed to cigarette smoke and RSV for 6 months and their corresponding controls. (C) Matrix accumulation was
assessed with trichrome staining in each mouse group and quantified by the Ashcroft fibrosis score. Representative images of mice lungs from each
group are presented here (scale bar = 20 mM; left panels). Fibrosis and inflammation scores were calculated for each treatment group (right panels
where n = 12 animals/group). Each graph is represented as mean 6 S.E.M. where each measurement was performed on 12 animals/group. p values
shown, comparing both treatments connected by a line.
doi:10.1371/journal.pone.0090567.g002
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system. Densitometry was performed on each target and
represented as a ratio of pixel intensity compared to actin, using
Bio-Rad Laboratories Image Lab software (version 4.0, build 16).
Terminal Deoxynucleotidyl Transferase dUTP Nick End-
labeling (TUNEL) Analysis
Apoptosis was determined on paraffin-embedded tissue by the
TUNEL in situ cell death detection kit AP (Roche Diagnostics),
using the instructions provided by the manufacturer. At least 10
random sections were obtained from each lung from 3 different
depths of sectioned tissue. After staining, a minimum of 1000 cells
was visually evaluated in each section. The labeled cells were
expressed as a percentage of total nuclei.
Phosphatase Levels
PP2A and PTP1B activities were determined as previously
described [35]. qPCR was performed for PTP1B and the A
subunit of PP2A using Taqman probes, under the same criteria as
described above.
Statistical Analyses
Data are expressed as means 6 S.E.M. We determined
statistical significance by Student t-tests (two tailed) using
GraphPad Prism Software (Version 5 for Mac OS X). Two-tailed
ANOVA repeat measure analysis was employed to determine the
changes in animal body weight over time. All data sets are
represented as mean +/2 standard error.
Results
Cigarette Smoke Enhances RSV Infection
Mice were administered a monthly dose of RSV either in
combination with daily cigarette smoke or room air, as depicted in
Figure 1A. Animals were sacrificed 10 days after receiving the final
dose of RSV, to eliminate a saturation of inflammation persisting
from the viral infection. Mice exposed to cigarette smoke gained
less weight over the study, which was amplified by repeated RSV
Figure 3. RSV infections enhance cigarette smoke induced airway enlargements. Lung morphology was determined in mice exposed to
cigarette smoke and RSV for 6 months and their corresponding controls. (A) Representative images (scale bar = 50 mM) and (B) mean linear intercepts
(MLI) of mice lungs from each group are presented here. Graph is represented as mean 6 S.E.M., where each measurement was performed on 12
animals/group. p values shown, comparing both treatments connected by a line.
doi:10.1371/journal.pone.0090567.g003












MMP-2 1.0060.13 1.2160.17 1.6560.30 4.5460.41#
MMP-8 1.0060.21 2.7360.38* 3.4560.83* 3.8260.75#
MMP-9 1.0060.05 1.9360.26* 1.8160.24* 1.2360.15
MMP-12 1.0060.13 1.8760.24* 6.7661.04* 7.8561.56#
MMP-13 1.0060.26 0.7460.11 3.9360.63* 4.3860.60#
MMP-14 1.0060.13 1.5960.04* 1.7560.16* 1.8160.16
MMP-16 1.0060.11 0.7260.18 1.5760.20* 1.8860.11#
MMP-19 1.0060.13 0.7860.07 1.1260.20 1.3660.17#
MMP-20 1.0060.31 0.4960.16 0.9560.30 1.7460.40#
MMP-23 1.0060.19 0.9960.08 0.4760.10* 0.7560.29
MMP-28 1.0060.23 0.7560.14 1.2260.39 1.8960.27#
Cathepsin A 1.0060.29 1.0260.04 0.5160.07 0.5560.16#
Cathepsin E 1.0060.43 3.9960.78* 5.8261.15* 7.5361.16#
Cathepsin F 1.0060.12 0.8060.12 0.5460.02* 0.8760.19
Cathepsin G 1.0060.26 2.7560.52* 3.9060.34* 4.9360.76
Cathepsin K 1.0060.19 1.3260.25 0.8260.13 0.7160.15#
Cathepsin L1 1.0060.06 0.8160.02* 0.7060.10* 0.9060.01
Cathepsin M 1.0060.16 1.8960.19* 1.7960.23* 2.1260.43
Cathepsin S 1.0060.11 1.6760.12* 5.0860.84* 7.1361.42#
Cathepsin W 1.0060.03 0.9160.14 5.3561.41* 6.0560.70#
Cathepsin Z 1.0060.16 0.7360.07 1.6260.05* 1.6560.12#
Values are represented as mean 6 S.E.M., where each measurement was
performed 3 times on 12 animals/group. Bold numbers denoted by *represents
a p value less than 0.05 compared to mock and room air treated mice.
#denotes a p value less than 0.05 compared to either smoke or RSV treated
mice.
doi:10.1371/journal.pone.0090567.t001
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infections (Figure 1B). Significant differences in body weight loss
were initially found between mock controls and RSV treated mice
after 140 days (p,0.05), between smoke and smoke/RSV treated
mice after 45 days (p,0.01) and between RSV and smoke/RSV
treated mice after 140 days (p,0.05). RSV was still detectable in
the lungs of mice 10 days post infection, by qPCR (Figure 1C) but
was undetectable by plaque assay (data not shown) as similarly
observed by other investigators [25]. Cigarette smoke exposed
mice had a higher RSV N copy number than room air exposed
mice (Figure 1C). Not surprisingly, exposure to RSV or smoke
alone lead to an infiltration of macrophages, neutrophils and
lymphocytes into the lung (Figure 1D). Interestingly, smoke
exposure synergistically enhanced RSV induced inflammation,
with macrophages, neutrophils and lymphocytes.
RSV Enhances Cigarette Smoke Inflammation and
Fibrosis
RSV and cigarette smoke-exposed mice exhibited perivascular
lymphocytic inflammation, which was additionally augmented by
exposure to both RSV and cigarette smoke (Figure 2A). An
inflammation score was also performed on the inflammatory cell
infiltration around the bronchial airways and the results were
comparable to the perivascular inflammation, with RSV enhanc-
ing smoke-induced inflammation (Figure 2B). Trichrome staining
demonstrated increased airway fibrosis in mice exposed to both
cigarette smoke and RSV infections (Figure 2C), with collagen
deposition observed around the airways. Ashcroft fibrosis scoring
confirmed increased fibrosis in mice exposed to both cigarette
smoke and repeat RSV infection (Figure 2C). Therefore, dual
stimulation with smoke and RSV infection lead to an exaggerated
inflammation and fibrotic airway remodeling response.
RSV Infections Enhance Cigarette Smoke Induced Airway
Remodeling
Others have demonstrated that short term smoke exposure in
combination with viral infection or poly (i:c) could enhance airway
remodeling in animal models [21,36]. To investigate the long-term
impact of combined smoke exposure and multiple viral infections
on lung remodeling, we examined airway remodeling by MLI
analysis. Not surprisingly, chronic cigarette smoke exposure alone
caused a significant increase in alveolar size determined morpho-
metrically by MLI (Figure 3). Interestingly, repeated RSV
infection also enhanced airspace enlargement (Figure 3A–B).
Combined stimuli of smoke and RSV induced a synergistic
enhancement of airway remodeling (Figure 3A–B).
RSV Infections Alter the Cigarette Smoke Induced Airway
Protease Response
Increased protease levels have been frequently observed in
human airway diseases [33,37]. The influence of exposures to viral
infection on smoke induced protease expression was investigated
by qPCR, multiplex analysis, immunoblots and activity assays
from tissue or BALF. C57BL/6J mice infected multiple times with
RSV have significant gene expression increases for matrix
metalloproteinases (MMP) -8, -9, -12, -13, -14, -16 and cathepsins
E, G, M, S, W and Z (Table 1; see Table S1 for gene expression of
remaining MMPs and cathepsins). Multiplex assays confirmed
increased MMP-2, -8, -9 and -12 in the BALF of RSV infected
mice (Figure 4A). RSV exposure also increased tissue protein levels
of cathepsin G, S and Z (Figure 4B–C). Smoke exposure induced
significant gene expression increases for MMP-8, -9, -12, -14 and
Figure 4. RSV infections enhance cigarette smoke induced airway protease response. (A) BALF MMP (-2, -8, -9 and -12) levels were
determined by multiplex analysis in the BALF of mice exposed to cigarette smoke and RSV for 6 months and their corresponding controls. Cathepsin
G, K, Z, E, S, W and MMP-28 lung protein expression levels were analyzed by (B) immunoblotting and (C) densitometry. Graphs are represented as
mean 6 S.E.M., where each measurement was performed 2 times on 12 animals/group. p values shown, comparing both treatments connected by a
line.
doi:10.1371/journal.pone.0090567.g004
Figure 5. RSV infections enhance cigarette smoke induced
cathepsin S activity. BALF protease activity was of mice exposed to
cigarette smoke and RSV for 6 months and their corresponding
controls. (A) Total BALF collagenase and cathepsin S relative activity was
determined. (B) Gelatinase activity was determined in BALF and
densitometry was performed for MMP-9 and MMP-2. Graphs are
represented as mean 6 S.E.M., where each measurement was
performed 3 times on 12 animals/group. p values shown, comparing
both treatments connected by a line.
doi:10.1371/journal.pone.0090567.g005
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cathepsins E, G, M and S (Table 1). Multiplex assays confirmed
increased MMP-8, -9 and -12 in the BALF of smoke exposed mice
(Figure 4A) and immunoblotting confirmed that smoke induced
cathepsin G, Z, E and S levels in tissue (Figure 4C). Combined
RSV infection and smoke exposure induced enhanced gene
expression of MMP-2, -8, -12, -13, -16, -19, -20, -28 and
cathepsins E, S, W and Z (Table 1). Multiplex assays confirmed
that smoke enhanced RSV-induced MMP-8 and -12 in the BALF
(Figure 4A). Tissue protein levels of cathepsin G, S and W were
also synergistically enhanced by smoke (Figure 4B–C). MMP-3
BALF protein levels were also examined to confirm qPCR data of
a protease that was unaltered by either stimuli and was confirmed
to be unchanged in all mouse groups (Figure S1 and Table S1).
Protease activities were also altered within the BALF of mice, with
repeat RSV or smoke exposure increasing collagenase, gelatinase
and cathepsin S activity in BALF of mice (Figure 5). Repeat RSV
exposure enhanced smoke induced cathepsin S activity in BALF of
mice but did not appear to enhanced total BALF collagenase
activity (Figure 5A). Interestingly, smoke alone increased MMP-9
gelatinase activity levels more so than RSV infection, which varied
from the qPCR and multiplex data (Figure 5B). Therefore, RSV
infections impacts on smoke associated protease production, which
may contribute to the airway remodeling observed in this animal
model.
RSV Infections Alter Cigarette Smoke Induced Airway
Cytokine Release
Microbial infection in the airways can contribute to disease
exacerbations, which have been associated with cytokine and
chemokine release from lung-residential cells [21]. C57BL/6J
mice infected multiple times with RSV have significant BALF
increases for IL-1a, IL-1b, IL-6, IL-10, IL-17, IFN-c, RANTES
and KC (Table 2; see Table S2 for cytokines unaltered by RSV or
smoke), determined by multiplex assays. Gene expression analysis
also identified increased IL-13, IL-27, CXCL9, CXCL10,
CXCL11, G-CSF, IFN-a and IFN-b in the tissue of RSV infected
mice (Table 3; see Table S3 for gene expression cytokines
unaltered by RSV or smoke). Smoke exposure alone-induced
increased BALF protein levels of IL-17, TNF-a and KC (Table 2).
Table 2. RSV infections alter cigarette smoke induced airway cytokine release.
Cytokine (pg/ml) Mock/Room air RSV/Room air Mock/Smoke RSV/Smoke
IL-1a 2.0760.36 30.1169.63* 1.1160.25 74.3568.62#
IL-1b 59.0966.20 78.7565.32* 55.7363.76 75.6068.40
IL-3 27.9160.83 22.7760.98* 24.8260.91* 21.7660.80
IL-5 4.6860.09 4.0760.20* 4.1660.13* 4.3760.36
IL-6 3.7860.44 9.63163.81* 4.56860.38 9.14762.75
IL-10 61.4369.92 76.45612.60* 35.4962.98* 59.78618.34
IL-13 48.4162.44 29.6163.50* 40.2361.77 33.5962.65#
IL-17 43.6665.06 64.1766.72* 81.62610.70* 122.4067.52#
IFN-c 12.1560.72 35.47611.26* 15.4961.30 80.15612.02#
RANTES 12.4160.84 107.30611.7* 12.3861.03 129.1611.73
TNF-a 524.90641.34 438.80655.48 609.10629.10* 508.4658.42#
MIP-2 10.5160.27 9.1060.18* 9.3160.29* 9.5360.34
GM-CSF 39.7262.99 30.4961.30* 35.0062.00 33.8862.64
CXCL1/KC 6.7961.34 18.9462.13 12.8361.85 21.5961.82
Values are represented as mean 6 S.E.M., where each measurement was performed 3 times on 12 animals/group. Bold numbers denoted by *represents a p value less
than 0.05 compared to mock and room air treated mice.
#denotes a p value less than 0.05 compared to either smoke or RSV treated mice.
doi:10.1371/journal.pone.0090567.t002












IL-1b 1.0060.08 2.9260.30* 2.0460.18 2.89060.43
IL-6 1.0060.25 3.0860.64* 2.0060.14 2.4360.09
IL-10 1.0060.37 3.4260.68* 2.1260.63 2.0060.34
IL-13 1.0060.43 6.5761.55* 14.0162.71* 17.1763.70#
IL-17 1.0060.28 3.6160.66* 2.6960.40* 6.6961.45#
IL-27 1.0060.21 2.6660.53* 1.4160.21 3.9561.42#
CXCL1/KC 1.0060.14 1.8560.24* 2.6160.23* 3.4260.31#
CXCL9 1.0060.29 14.4761.01* 5.6961.43* 17.7562.35#
CXCL10 1.0060.42 4.8860.62* 2.6560.24* 2.8660.22
CXCL11 1.0060.09 6.6461.35* 3.4760.88* 4.2561.22
RANTES/
CCL5
1.0060.19 13.4462.59* 2.9961.02* 19.0465.40#
MIF 1.0060.14 0.4960.04* 0.8760.08 1.4360.05#
GM-CSF 1.0060.11 1.6060.20 1.5960.30 2.4460.36#
G-CSF 1.0060.40 2.1160.65* 1.2060.53 1.0760.19
IFN-a 1.0060.25 3.8160.91* 4.1561.05* 2.8761.17
IFN-b 1.0060.15 4.7160.83* 2.3360.38* 2.8860.65
IFN-c 1.0560.30 14.6162.23* 2.6460.62* 20.1063.61#
Values are represented as mean 6 S.E.M., where each measurement was
performed 3 times on 12 animals/group. Bold numbers denoted by *represents
a p value less than 0.05 compared to mock and room air treated mice.
#denotes a p value less than 0.05 compared to either smoke or RSV treated
mice.
doi:10.1371/journal.pone.0090567.t003
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Increased gene expressions of IL-13, CXCL9, CXCL10,
CXCL11, RANTES, IFN-a, IFN-b and IFN-c were observed
after 6 months of smoke exposure (Table 3). Combined smoke and
RSV infection lead to an enhanced induction of IL-1a, IL-17,
IFN-c and KC in the BALF and IL-13, IL-27, CXCL9,
RANTES, MIF and GM-CSF by qPCR (Table 2 and Table 3).
Therefore, combined exposure to cigarette smoke and RSV can
synergistically enhance certain immune responses. Equally, trend
decreases in several BALF cytokines were observed following dual
stimulation of smoke and RSV infection, such as IL-2, IL-3, IL-5,
Figure 6. RSV infections enhance cigarette smoke induced airway cell death. (A) TUNEL analysis was performed on lung tissue from mice
exposed to cigarette smoke and RSV for 6 months and their corresponding controls. Graph represented as mean 6 S.E.M., where each measurement
was performed on 12 animals/group. p values shown, comparing both treatments connected by a line. (B) Representative images of TUNEL staining
of mice lungs from each group are presented here (scale bar = 50 mM).
doi:10.1371/journal.pone.0090567.g006
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IL-7, IL-9, IL-10, IL-12p70, IL-13, TNF-a, VEGF, MIP1a, and
MIP1b (Tables 2 and S2). Altered cytokine levels were probably
not dependent on AP-1 or NF-kB activation, as dual exposure did
not enhance activity of either transcription factor (Figure S2).
However, additional studies are required to fully confirm this
observation.
RSV Infections Enhance Cigarette Smoke Induced Airway
Cell Death
Studies were undertaken to evaluate the impact of RSV and
smoke exposure on cell death responses in the mouse lung. In cell
culture, cigarette smoke causes necrosis rather than virus-induced
apoptosis [38]. Our in vivo analysis demonstrated that administra-
tion of either smoke or RSV to mice caused significant increases in
the number of cells that were undergoing apoptosis (Figure 6).
RSV caused significant increase in the number of TUNEL positive
cells. Smoke alone induced a modest induction of TUNEL positive
cells within the lung. However, the combined exposure to smoke
and RSV induced the most impressive changes with the detection
of many TUNEL positive cells (Figure 6). An increase in the
number of TUNEL-positive cells was seen in the bronchial airways
of smoke exposed mice that were treated with RSV (Figure 6B).
RSV Infection Subdued PTP1B and PP2A Expressions and
Activities
Chronic cigarette smoke exposure subdues the PTP1B and
PP2A anti-inflammation response [35,39] and viruses can prevent
PP2A activity [40]. Therefore, we investigated whether dual
exposure to smoke and RSV infections could enhance inflamma-
tion by preventing the inductions of airway PTP1B and PP2A. As
observed before [35,39], chronic smoke exposure did not induce
PTP1B and PP2A activity (Figure 7). RSV inhibited PP2A and
PTP1B activities, which was further enhanced by smoke exposure
(Figure 7). Exposure to both smoke and RSV significantly reduced
gene expression of both phosphatases (Figure 7).
Discussion
An exacerbation is a seminal event in the life of a COPD patient
that frequently marks the transition from relative stability to a
more rapid decline in lung function. Given the importance of
exacerbations in the severity and progression of the disease, it is
critical to establish the mechanisms by which an exacerbation
leads to a decline in lung function. It has long been observed that
RSV infections are frequently detected in the lungs of COPD
patients during an exacerbation [16]. Moreover, RSV is known to
persist in the lung even after an exacerbation has appeared to
resolve [17]. What this study shows is that the presence of RSV
infection exacerbates the underlying inflammatory, proteolytic and
apoptotic responses triggered by cigarette smoke exposure in the
lung. Indeed, RSV exposure significantly enhanced lung tissue
destruction in smoke exposed mice. This study is also the first
study to examine the impact of repeat viral infections in animals
actively exposed to smoke throughout the study and suggests that
inhibition of phosphatase activities may contribute to the
inflammation observed in COPD viral exacerbations. Further-
more, these results indicate the specific strategies aimed at
preventing and treating RSV infection would have a significant
impact on COPD development.
RSV exposure exacerbated the protease/anti-protease imbal-
ance in the lungs of the smoke-exposed mice. This finding was not
altogether surprising as RSV induces MMP-3 and -10 expression
Figure 7. Smoke enhances RSV inhibition of PTP1B and PP2A activities. Lung tissue from C57BL/6J mice was examined for gene expression
and phosphatase activity for (A) PP2A and (B) PTP1B. Graphs are represented as mean 6 S.E.M., where each measurement was performed on 12
animals/group. p values shown, comparing both treatments connected by a line.
doi:10.1371/journal.pone.0090567.g007
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in nasal epithelial cells [41,42], MMP-9 expression in human
bronchial epithelial cells [43,44] and MMP-9 and -2 in a BALB/c
mouse model [45]. However, the diversity of proteases that were
regulated by RSV was impressive and this likely has a wide-
ranging biological impact on the lung. Certainly, the role of
proteases in emphysema is well established [46,47] and RSV
induced emphysematous changes in mice that were further
exacerbated by cigarette smoke exposure. It is conceivable that
the proteolytic response may mediate the clearance of RSV
infections from the lung. Indeed, collagen and elastin peptides
exert chemotactic effects that draw in inflammatory cells that are
needed for the elimination of viral infections in the lung [48].
However, it is also possible that proteases may delay viral
clearance by degrading proteins that bind RSV and eliminate it
from the lung. In fact, proteases degrade surfactant protein A [49],
which clears RSV from the lung [50], as well as secretory
leukoprotease inhibitor (SLPI), elafin and SerpinB1, which have
been reported to exert antiviral effects [51,52]. Whether all of the
proteases identified in this study are present in human viral
exacerbations or contribute to disease progression or viral
clearance is yet to be determined but the role of each protease
in COPD progression represents many potential future topics of
interest. The mechanism by which RSV enhances smoke induced
proteases also represents an important area for future investiga-
tion. Smoke and RSV have several common targets that could
impact on protease production, such as TLR4 [53,54], TLR9
[53], RIG-I [21]. We have previously observed increased protease
induction in the absence of PP2A [39] and PTP1B [35]
expression. Loss of phosphatase responses could play a major
part on the proteases expressed in this study. Equally, phospha-
tases can regulate cytokine production, which may also contribute
to the protease production observed in this study.
The induction of cytokines is necessary to clear viral infections
like RSV that contribute to lung injury and disease progression.
Many of the cytokines induced by RSV exposure in our model
have also been linked with apoptosis, protease expression, mucus
metaplasia and lung tissue destruction in COPD [55,56]. Virus-
associated exacerbations have greater loss in lung function and
increased CCL5, CXCL10, and CXCL11 [57], which were also
observed in our mouse model. COPD patients have increased
IFN-c in BALF fluid [32], possibly from smoke induced CD8+ T
cells that are a key regulator of the inflammation response in
COPD [58]. IFN-c primes cytotoxic T cell responses against RSV
infection that are important for eliminating the virus from the
lung. However, persistent or repeated viral infections, as occurred
in our model, leads to chronic upregulation of IFN-c in the lung,
which induces protease expression, apoptosis and emphysema in
mice [55] and is associated with disease severity in humans. Loss of
PTP1B expression leads to increased smoke induced IFN-c and
IL-17 in the lungs of mice [35]. IL-17, which was induced in our
model, modulates airway hyperreactivity and emphysema forma-
tion in mice [59]; however, the expression of IL-17 is required for
the clearance of bacterial and viral infections in the lung. Indeed,
there is some data to suggest that deficient cytokine responses
could impair viral clearance from the lung [60], which based on
our findings would exacerbate inflammatory and emphysematous
changes in the lung. NF-kB and interferon stimulatory response
element (ISRE) have been associated with smoke enhanced RSV
stimulated cytokines [61]. We do not see a synergistic enhance-
ment of NF-kB activation but we specifically examined animals at
the end of the infection. Perhaps smoke may alter NF-kB earlier
during the infection. This and the role of ISREs in viral and smoke
responses will be an area of future investigation.
Large increases in TUNEL positive epithelial cells were
detected in our RSV infected mice and this increase was further
enhanced by smoke exposure. This is significant as there have
been conflicting reports about the role of RSV in airway epithelial
cell death and survival. One group showed that RSV inhibits
apoptosis and prolongs survival by downregulating p53 or
stimulating epidermal growth factor receptor (EGFR) and
phosphatidylinositol 3-kinase (PI3K) signaling in lung epithelial
cells [62,63,64]. On the other hand, others have reported that
RSV sensitizes the epithelium to apoptosis by strongly upregulat-
ing the expression of tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL) [65] or CD95 (fas) [66,67]. Emphyse-
matous airways are extremely sensitivity to TRAIL-mediated
apoptosis [68], which may account for the increased apoptosis
observed in our study following smoke and RSV exposures.
TRAIL receptors are overexpressed in human emphysema
patients [69] and their expression is sensitive to oxidative stress
such as H2O2 stimulation. RSV infections coincide with increased
soluble TRAIL levels in the BALF of respiratory failure patients
[70]. Equally, RSV has been shown to reduce NRF2 in animal
models [71]. NRF2 regulates numerous cell survival genes [72]
and anti-oxidants [71] that are key players in mediating
inflammation [35,73]. PTP1B and PP2A activities are sensitive
to oxidation [35] and inhibition of PP2A increases sensitivity to
TRAIL signaling [74]. It is interesting to note that the intense
apoptotic responses in the airways in this study were accompanied
by significant airway inflammation and fibrosis. Thus, determining
how epithelial cell death leads to airway fibrosis would shed
important insights in the pathophysiologic changes that occur in
this disease.
Little clinical data is available on RSV susceptibility and
inflammatory markers in COPD patients. However other viruses
can give us a potential depiction of the human airway responses to
RSV. Experimental rhinovirus studies in humans confirm that
viral load correlates strongly with inflammatory markers [60].
BALF cells from COPD patients infected ex vivo with rhinovirus
have deficient IFN-b induction, which coincides with reduced
IFN-stimulated gene CXCL10 [60]. However, others have
reported enhanced inflammation in tracheobronchial cells from
COPD patients compared to healthy donor cells [75]. Our in vivo
model observed enhanced inflammation from BALF and lung
tissue after RSV infection. Future clinical studies will be required
to determine how RSV infection impacts on the inflammatory
responses in COPD.
The role of RSV in the progression of COPD has been debated
as the virus is detected in up to a third of stable COPD subjects
[17]. However, our findings affirm that RSV is not merely a
colonizer of the lung but rather a key etiologic factor driving
cytokine, protease and apoptotic responses that lead to air space
enlargement and airway fibrosis. In fact, RSV exposure by itself
induced biological and structural changes that were at least as
severe as cigarette smoke exposure. Whether smoke exposure is
enhancing RSV inflammation synergistically or accumulatively
still remains to be determined but our data suggests that synergistic
inhibition of phosphatase activities may be playing a major role in
COPD exacerbations. These results provide a clear rationale for
developing better RSV prevention and treatment strategies as a
means of countering the progression and severity of this disease.
This data indicates that the detecting RSV may help identify those
subjects who are likely to experience a clinical deterioration over
time.
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Supporting Information
Figure S1 RSV infections and cigarette smoke had no impact on
MMP-3 BALF levels. BALF MMP-3 levels were determined by
multiplex analysis in the BALF of mice exposed to cigarette smoke
and RSV for 6 months and their corresponding controls. Graph is
represented as mean 6 S.E.M., where each measurement was
performed 2 times on 12 animals/group.
(TIF)
Figure S2 AP-1 and NF-kB activities following RSV and smoke
stimuli. Transcription factor (AP-1 and NF-kB) activation was
examined in the lungs of mice exposed to cigarette smoke and
RSV for 6 months and their corresponding controls. Graphs are
represented as mean 6 S.E.M., where each measurement was
performed 2 times on 12 animals/group. p values shown,
comparing both treatments connected by a line.
(TIF)
Table S1 Protease gene responses in airways to RSV infections
and cigarette smoke exposure.
(PDF)
Table S2 Cytokine release in airways to RSV infections and
cigarette smoke exposure.
(PDF)
Table S3 Cytokine gene responses in airways to RSV infections
and cigarette smoke exposure.
(PDF)
Methods S1 NFB and AP1 activation.
(PDF)
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